Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomas Koltai

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
European Journal of Clinical Nutrition|September 3, 2020
The Ph paradigm in cancerTomas Koltai
F1000Research|June 23, 2015
Nelfinavir and other protease inhibitors in cancer: mechanisms involved in anticancer activityTomas Koltai
Cancer Drug Resistance (Alhambra, Calif.)|July 8, 2022
The complex relationship between multiple drug resistance and the tumor pH gradient: a reviewTomas Koltai
Oncotargets and Therapy|March 28, 2014
Clusterin: a key player in cancer chemoresistance and its inhibitionTomas Koltai
International Journal of Molecular Sciences|December 8, 2020
Targeting the pH Paradigm at the Bedside: A Practical ApproachTomas Koltai
Oncotargets and Therapy|November 2, 2016
Cancer: fundamentals behind pH targeting and the double-edged approachTomas Koltai
Cancers|September 28, 2023
Earlier Diagnosis of Pancreatic Cancer: Is It Possible?Tomas Koltai
Seminars in Cancer Biology|January 26, 2017
Triple-edged therapy targeting intracellular alkalosis and extracellular acidosis in cancerTomas Koltai
F1000Research|July 14, 2016
Voltage-gated sodium channel as a target for metastatic risk reduction with re-purposed drugsTomas Koltai
Journal of Evidence-Based Integrative Medicine|January 12, 2022
Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and QuestionsTomas Koltai, Larry Fliegel
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
European Journal of Clinical Nutrition|September 3, 2020
The Ph paradigm in cancerTomas Koltai
F1000Research|June 23, 2015
Nelfinavir and other protease inhibitors in cancer: mechanisms involved in anticancer activityTomas Koltai
Cancer Drug Resistance (Alhambra, Calif.)|July 8, 2022
The complex relationship between multiple drug resistance and the tumor pH gradient: a reviewTomas Koltai
Oncotargets and Therapy|March 28, 2014
Clusterin: a key player in cancer chemoresistance and its inhibitionTomas Koltai
International Journal of Molecular Sciences|December 8, 2020
Targeting the pH Paradigm at the Bedside: A Practical ApproachTomas Koltai
Oncotargets and Therapy|November 2, 2016
Cancer: fundamentals behind pH targeting and the double-edged approachTomas Koltai
Cancers|September 28, 2023
Earlier Diagnosis of Pancreatic Cancer: Is It Possible?Tomas Koltai
Seminars in Cancer Biology|January 26, 2017
Triple-edged therapy targeting intracellular alkalosis and extracellular acidosis in cancerTomas Koltai
F1000Research|July 14, 2016
Voltage-gated sodium channel as a target for metastatic risk reduction with re-purposed drugsTomas Koltai
Journal of Evidence-Based Integrative Medicine|January 12, 2022
Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and QuestionsTomas Koltai, Larry Fliegel
Pageof 3